MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Validation of the Hebrew version of the Unified Dyskinesia Rating Scale (UDysRS)

    A. Socher, A. Thaler, H. Shabtai, J. Zitser, T. Shainer, M. Kestenbaum, A. Rosenberg, A. Bar David, A. Ezra, T. Taichman, M. Brozgol, T. Herman, G. Stebbins, C. Goetz, S. Luo, P. Martinez-Martin, N. Giladi, T. Gurevich (Mdrid, Spain)

    Objective: To assess the clinimetric properties of the Hebrew version of the UDysRS. Background: Dyskinesia is a common side effect of dopaminergic treatments for Parkinson's…
  • 2019 International Congress

    Impaired intracortical inhibition predicts response to medication in Parkinson’s disease patients

    SR. Filipović, A. Kačar, S. Milanović, M. Ljubisavljević, VS. Kostić (Beograd, Serbia)

    Objective: To check whether measures of motor cortex excitability and plasticity are associated with clinical response to dopaminergic treatment in Parkinson’s disease (PD) patients. Background:…
  • 2019 International Congress

    Characterising the role of alpha-synuclein in ferroptotic programmed cell death in the context of Parkinson’s Disease

    L. Mahoney-Sánchez, H. Bouchaoui, K. Timmerman, A. Jonneaux, S. Ayton, J. Duce, JC. Devedjian, D. Devos (Lille, France)

    Objective: Despite the involvement of alpha synuclein (α-syn) pathology in Parkinson's disease (PD) pathology, the consequences on the neuropathology and the type of programmed cell…
  • 2019 International Congress

    Comparison of LFP-physiomarkers for DBS programming

    G. Wenzel, S. Ewert, A. Horn, B. van Wijk, A. Kühn (Berlin, Germany)

    Objective: To evaluate clinical usability of LFP(local field potentials)-physiomarkers and lead localisation for selection of suitable DBS electrode configurations. Background: Selection of optimal contacts in…
  • 2019 International Congress

    Touching Nose: Alleviating Maneuvers (Sensory Tricks) in Orofacial Dystonia

    NG. Bülbül, MG. şenol (Istanbul, Turkey)

    Objective: Orofacial dystony is a type of focal dystonia that affects the facial and masticatory, cervical, laryngeal, eyelid, and pharyngeal muscles. Background: We present a…
  • 2019 International Congress

    Botulinum toxin content and activity: Potential implications for duration of efficacy in patients with cervical dystonia

    M. Field, A. Splevins, M. Schans, J. Langenberg, D. Noort, P. Picaut, K. Foster (Rijswijk, Netherlands)

    Objective: To quantify the amount of botulinum neurotoxin-A (BoNT-A) protein in each vial of commercial BoNT-A product and compare light chain activity of 150 kDa…
  • 2019 International Congress

    Long-term treatment of cervical dystonia with abobotulinumtoxinA

    A. Jochim, T. Meindl, T. Mantel, S. Zwirner, F. Castrop, B. Haslinger (Munich, Germany)

    Objective: To evaluate long-term efficacy and safety of the treatment of cervical dystonia (CD) with abobotulinumtoxinA in daily life routine in an outpatient clinic for…
  • 2019 International Congress

    Combined Botulinum Toxin and Gpi DBS therapy in intractable cervical dystonia

    AM. Macerollo, BH. Hammersley, ME. Esposito, JS. Somerset, RE. Ellis, MB. Bonello, JP. Panicker, DD. Damodoran, JOF. Farah, PE. Eldridge, SA. Alusi (Naples, Italy)

    Objective: To test whether the reintroduction of Botulinum Toxin Injections (BTI) after Globus pallidus interna Deep Brain Stimulation (Gpi-DBS) for intractable cervical dystonia synergistically improves…
  • 2019 International Congress

    Trust the Patient’s Report, not the Doctor’s: Non-Motor Symptoms and Quality of Life in Cervical Dystonia

    I. Ndukwe, J. Dover, P. Lynch, C. O'Neill, S. O'Riordan, M. Hutchinson (Dublin, Ireland)

    Objective: To assess the prevalence of mood disorder and measure health-related quality of life (Hr-QoL) in relation to, pain, disability and disease severity in cervical…
  • 2019 International Congress

    Pregnancy and Delivery Complications in Women with Inherited Isolated Dystonia

    M. San Luciano, V. Shanker, S. Bressman, D. Raymond, R. Saunders-Pullman (San Francisco, CA, USA)

    Objective: To determine whether female mutation carriers of inherited dopa-responsive (DRD) and DYT/TOR1A genes had higher pregnancy and delivery complications than non-carriers Background: Women with…
  • 1
  • 2
  • 3
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley